Case report: Five cases of recurrent meningitis associated with chronic strongyloidiasis

American Journal of Tropical Medicine and Hygiene

Volumn 92, Issue 3, 2015, Pages 601-604

  Shimasaki, Teppei ^a   Chung, Heath ^a   Shiiki, Soichi ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b Okinawa Prefectural Chubu Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN; TIABENDAZOLE; ANTHELMINTIC AGENT;

ABDOMINAL DISTENSION; ADULT; ANTIBIOTIC THERAPY; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID CULTURE; CEREBROSPINAL FLUID CYTOLOGY; CHRONIC DISEASE; CLINICAL ARTICLE; DISEASE ASSOCIATION; ESCHERICHIA COLI; FECES CULTURE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HERPES LABIALIS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; KLEBSIELLA PNEUMONIAE; LOSS OF APPETITE; MALE; MENINGITIS; RESPIRATORY TRACT DISEASE; REVIEW; SEROLOGY; STREPTOCOCCUS EQUINUS; STRONGYLOIDIASIS; TREATMENT DURATION; VIRUS INFECTION; WEIGHT REDUCTION; AGED; COMPLICATION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN T-LYMPHOTROPIC VIRUS 1; MENINGITIS, BACTERIAL; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; YOUNG ADULT;

ESCHERICHIA COLI; HUMAN T-LYMPHOTROPIC VIRUS 1; KLEBSIELLA PNEUMONIAE; STREPTOCOCCUS BOVIS;

ADULT; AGED; ANTHELMINTICS; CHRONIC DISEASE; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IVERMECTIN; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; RETROSPECTIVE STUDIES; STRONGYLOIDIASIS; THIABENDAZOLE; YOUNG ADULT;

EID: 84924262898     PISSN: 00029637     EISSN: 14761645     Source Type: Journal    
DOI: 10.4269/ajtmh.14-0564     Document Type: Review

References (20)

1. Adriani KS, van de Beek D, Brouwer MC, Spanjaard L, de Gans J, 2007. Community-acquired recurrent bacterial meningitis in adults. Clin Infect Dis 45: e46-e51.
2. Mejia R, Nutman TB, 2012. Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis 25: 458-463.
3. Vadlamudi RS, Chi DS, Krishnaswamy G, 2006. Intestinal strongyloidiasis and hyperinfection syndrome. Clin Mol Allergy 4: 8.
4. Keiser PB, Nutman TB, 2004. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17: 208-217.
5. Somin M, Neogolani V, Zimhony O, Wolpart A, Sokolowski N, Malnick S, 2008. Fatal recurrent bacterial meningitis: a complication of chronic Strongyloides infection. Eur J Intern Med 19: e42-e43.
6. Link K, Orenstein R, 1999. Bacterial complications of strongyloidiasis: Streptococcus bovis meningitis. South Med J 92: 728-731.
7. Schär F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H, Vounatsou P, Odermatt P, 2013. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis 7: e2288.
8. Siddiqui AA, Berk SL, 2001. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 33: 1040-1047.
9. Berk SL, Verghese A, Alvarez S, Hall K, Smith B, 1987. Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee. Arch Intern Med 147: 1257-1261.
10. Sasaki Y, Taniguchi T, Kinjo M, McGill RL, McGill AT, Tsuha S, Shiiki S, 2013. Meningitis associated with strongyloidiasis in an area endemic for strongyloidiasis and human T-lymphotropic virus-1: a single-center experience in Japan between 1990 and 2010. Infection 41: 1189-1193.
11. Mak DB, 1993. Recurrent bacterial meningitis associated with Strongyloides hyperinfection. Med J Aust 159: 354.
12. Vandebosch S, Mana F, Goossens A, Urbain D, 2008. Strongyloides stercoralis infection associated with repetitive bacterial meningitis and SIADH: a case report. Acta Gastroenterol Belg 71: 413-417.
13. Hayashi J, Kishihara Y, Yoshimura E, Furusyo N, Yamaji K, Kawakami Y, Murakami H, Kashiwagi S, 1997. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan. Am J Trop Med Hyg 56: 71-75.
14. Satoh M, Toma H, Sato Y, Takara M, Shiroma Y, Kiyuna S, Hirayama K, 2002. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1. Clin Exp Immunol 127: 354-359.
15. Requena-Méndez A, Chiodini P, Bisoffi Z, Buonfrate D, Gotuzzo E, Muñoz J, 2013. The laboratory diagnosis and follow up of strongyloidiasis: a systematic review. PLoS Negl Trop Dis 7: e2002.
16. Marra NM, Chiuso-Minicucci F, Machado GC, Zorzella-Pezavento SF, França TG, Ishikawa LL, Amarante AF, Sartori A, Amarante MR, 2010. Fecal examination and PCR to detect Strongyloides venezuelensis in experimentally infected Lewis rats. Mem Inst Oswaldo Cruz 105: 57-61.
17. Karunajeewa H, Kelly H, Leslie D, Leydon J, Saykao P, Biggs BA, 2006. Parasite-specific IgG response and peripheral blood eosinophil count following albendazole treatment for presumed chronic strongyloidiasis. J Travel Med 13: 84-91.
18. Biggs BA, Caruana S, Mihrshahi S, Jolley D, Leydon J, Chea L, Nuon S, 2009. Management of chronic strongyloidiasis in immigrants and refugees: is serologic testing useful? Am J Trop Med Hyg 80: 788-791.
19. Bisoffi Z, Buonfrate D, Angheben A, Boscolo M, Anselmi M, Marocco S, Monteiro G, Gobbo M, Bisoffi G, Gobbi F, 2011. Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis. PLoS Negl Trop Dis 5: e1254.
20. Grove DI, 1982. Strongyloides ratti and S. stercoralis: the effects of thiabendazole, mebendazole, and cambendazole in infected mice. Am J Trop Med Hyg 31: 469-476.